Editorial Board

Editors-in-Chief

James Henderson Naismith, Ph.D.

Rosalind Franklin Institute, the University of Oxford, Oxford, UK

Prof. Naismith obtained his B.S. and Ph.D. degrees from University of Edinburgh and University of Manchester (UK), respectively. After finishing his postdoctoral training at the University of Texas Southwestern Medical Center (USA), Dr. Naismith became a faculty member at University of St Andrews (UK). Currently, Dr. Naismith is the professor and Director of the Research Complex at Harwell, and the director of Rosalind Franklin Institute, University of Oxford. He has published nearly 300 papers on international journals including Nature, Nature Structural & Molecular Biology, Nature Communications, Nucleic Acids Research and PNAS. Renowned for his investigations of protein structure by X-ray crystallography and targeted therapy by small molecules, Dr. Naismith is elected as a fellow of the Royal Society (UK), the Academy of Medical Sciences (UK), the Royal Society of Edinburgh, the Royal Society of Chemistry and the Royal Society of Biology (UK).

Photo of Guangping Gao, Ph.D.

Guangping Gao, Ph.D.

Department of Genetic and Cellular Medicine, Horae Gene Therapy Center and Viral Vector Core, Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Massachusetts, USA

Dr. Gao is an internationally recognized gene therapy researcher who has played a key role in the discovery and characterization of new family of adeno-associated virus (AAV) serotypes, which was instrumental in reviving the gene therapy field, hugely impacting many currently untreatable human diseases. He has primarily focused on novel viral vector discovery for in vivo gene delivery, vectorology, vector biology and manufacturing, large animal modeling, preclinical, translational, clinical gene therapeutics and novel gene therapy platform technology development. He has published 400+ research papers in journals including Nature, Nat. Biotech., Nat. Drug Rev., Cell, etc. He holds 260+ patents. He serves as Executive Editor-In- Chief of Human Gene Therapy, Senior Editor of the Gene and Cell Therapy and on Editorial Boards of several journals. Dr. Gao had been ranked as the World Top 20 Translational Researchers by Nature Biotechnology. He is now elected fellows of both the US National Academy of Inventors (NAI) and American Academy of Microbiology; he was also the Past president of American Society of Gene and Cell Therapy.

Yu-quan Wei, Ph.D.

State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Yu-quan Wei, Ph.D., Professor and Director of National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu. He was educated at West China University of Medical Sciences for a bachelor's degree in Medicine and a Master's Degree in Medicine, and educated at Kyoto University in Japan for a Doctoral Degree. His major research interests include targeted therapy, signal transduction, gene and cell therapy, and cancer vaccines. He has published more than 300 papers in international journals including Nat Med, Nat Commun, PNAS, Blood, Cancer Res, Clinic Cancer Res, J Immunol, and J Biol Chem, etc. He was selected as an academician of Chinese Academy of Sciences in 2003. He is now President of China Medicinal Biotech Association. He has served as an associate editor of Human Gene Therapy and Editorial Board Member of several International Journals.

Associate Editors

Max S. Cynader, Ph.D., University of British Columbia, Vancouver, Canada

Mohan Edirisinghe, Ph.D., University College London, London, UK

J. Silvio Gutkind, Ph.D., University of California, San Diego, CA, USA

Canhua Huang, Ph.D., State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China

Peter E Huber, M.D., Ph.D., German Cancer Research Center, Heidelberg, Germany

Edouard Collins Nice, Ph.D., Monash University, Clayton, Victoria, Australia

Yong Peng, Ph.D., State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China

Shazib Pervaiz, Ph.D., National University of Singapore, Singapore

Akihide Ryo, M.D., Ph.D., Yokohama City University School of Medicine, Yokohama-shi, Japan

Giannino Del Sal, Ph.D., University of Trieste, Trieste, Italy

Michael Y Sherman, Ph.D., Ariel University, Ariel, Israel

Koichi Tanaka, Ph.D., Department of Transplantation and Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Henning Ulrich, Ph.D., Universidade de São Paulo, São Paulo, Brazil

Francesco Di Virgilio, M.D., University of Ferrara, Ferrara, Italy

Kang Zhang, M.D., Ph.D., Macau University of Science and Technology, Macau, China

Song Guo Zheng, Shanghai Jiao Tong University, Shanghai, China

Yi Zhun Zhu, M.D, Macau University of Science and Technology, Macau, China

Editorial Board Members

Svetlana Antonyuk, Ph.D., University of Liverpool, Liverpool, UK

Rami I. Aqeilan, Ph.D., Hebrew University-Hadassa Medical Center, Jerusalem, Israel

Horacio Cabral, Ph.D., University of Tokyo, Tokyo, Japan

George A. Calin, M.D., Ph.D., MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Yu Chen, Ph.D., Wuhan University, Wuhan, China

Zhe-sheng (Jason) Chen, M.D., Ph.D., St. John’s University, Queens, NY, USA

Alexander Choukér, M.D, LMU Hospital, Ludwig-Maximilians-Universität, Munich, Germany

Eric Deutsch, M.D, Ph.D., Institute Gustave Roussy, Villejuif, France

Arnold J.M. Driessen, Ph.D., University of Groningen, Groningen, Netherlands

Dongsheng Duan, Ph.D., University of Missouri, Columbia, MO, USA

Masanori Fukushima, M.D., Ph.D., Translational Research Center for Medical Innovation, Kobe, Japan

Daming Gao, Ph.D, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China

Xiangyu Gao, Peking University, Beijing, China

Ming-Liang He, Ph.D., City University of Hong Kong, Hong Kong, China

Timothy Hla, Ph.D., Harvard Medical School, Boston Children's Hospital, Harvard University, Boston, MA, USA

Zhen Huang, Ph.D., Georgia State University, Atlanta, GA, USA

Peter Illes, Ph.D., University of Leipzig, Leipzig, Germany

Lars Ittner, M.D., Dementia Research Centre, Macquarie University, Sydney, Australia

Peng Jiang, Ph.D., Tsinghua University, Beijing, China

Ke Lan, Ph.D., Wuhan University, Wuhan, China

Shuo Lin, Ph.D., University of California, Los Angeles, CA, USA

Yih-Cherng Liou, Ph.D., National University of Singapore, Singapore

Bolin Liu, M.D, Louisiana State University, New Orleans, USA

Xingguo Liu, Chinese Academy of Sciences, Guangzhou, China

Miguel López, Ph.D, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

Qing Richard Lu, Ph.D., Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

Pralay Maiti, Ph.D., Indian Institute of Technology, Banaras Hindu University, Varanasi, UP, India

Tobias Moser, M.D., University Medical Center Göttingen，Göttingen, Germany

Chitta Ranjan Patra, Ph.D., CSIR-Indian Institute of Chemical Technology, Hyderabad, India

Charles A. Powell, M.D., Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Zhiyong Qian, Ph.D., State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China

Kenneth S. Ramos, M.D, Ph.D, Texas A&M University, Houston, USA

Matthew Sachs, Ph.D., Texas A&M University, College Station, TX, USA

Alexey V. Semyanov, Ph.D., Russian Academy of Sciences, Moscow, Russia

Tsukasa Seya, M.D., Ph.D., Aomori University, Aomori, Japan

Hong-bing Shu, Ph.D., Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China

Weihong Song, M.D., Ph.D., The University of British Columbia, Vancouver, Canada

Yungan Tao, M.D., Institute Gustave Roussy, Villejuif, France

Vinay Tergaonkar, Ph.D., National University of Singapore, Singapore

Rajender Varma, Ph.D., US EPA, Cincinnati, Ohio, USA

Alexei Verkhratsky, M.D., Ph.D., The University of Manchester, Manchester, UK

Jun Wang, Ph.D, Rutgers University, Piscataway, USA

Rong Xiang, M.D., Nankai University, Tianjin, China

Eitan Yefenof, Ph.D., Hebrew University, Jerusalem, Israel

Ali Önder Yildirim, Ph.D, Helmholtz Zentrum München, Munich, Germany

Jian Yuan, Ph.D., School of Medicine, Tongji University, Shanghai, China

Jianjun Zhang, MD, PhD, The University of Texas, Houston, USA

Yonghui Zhang, Huazhong University of Science and Technology, Wuhan, China

Editorial Staff

Cherish Lee

Senior Editor

Cherish Lee received her B.A. degree from Southwest University and Ph.D. degree from University of Chinese Academy of Sciences. Before joining MedComm, she worked in Sichuan University. At present, she is the Senior Editor of MedComm.

Bing Han, Dr. Med

Senior Editor

Bing Han joined MedComm in January 2024. After graduated from Huazhong University of Science and Technology with bachelor and master of medicine, he received his Doctor of medicine from Ludwig-Maximillians University Munich where he studied stress and programmed cell death. He then continued to carry out his postdoctoral research on stress and immunity during spaceflight in Hospital of LMU Munich. At present he is the Senior Editor of MedComm.

Maggie Wang, PhD

Senior Editor

Maggie joined the MedComm editorial team in June 2023. She completed her PhD at Sichuan University National Key Laboratory of Biotherapy, where she researched mental and neurodegenerative disorders, examining the effects of misfolded protein buildup using clinical studies and animal models. At present she is the Senior Editor of MedComm.

Publisher

Janetta Li

Publishing Development, Health Sciences, Beijing, China